跳至主要内容
临床试验/EUCTR2013-002415-10-NL
EUCTR2013-002415-10-NL进行中(未招募)不适用

[18F]-labelled FDHT in PET/CT for detection and staging of bone metastases in hormone naïve prostate cancer - [18F]FDHT PET in hormone naive prostate cancer

niversity Medical Center Groningen0 个研究点开始时间: 2013年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • metastasized prostate cancer, =2 lesions in bone, onfirmed by visible lesions on bone scan, CT and/or MRI consistent with disease
  • no other known malignancies
  • no previous androgen deprivation therapy
  • informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • active cancer besides prostate cancer
  • previous androgen deprivation therapy
  • no informed consent
  • imminent pathological fractures or spinal cord lesions as a result of metastases that require immediate start of androgen deprivation therapy

研究者

相似试验